The One Health Company, a San Francisco, CA-based startup that aims to make canine cancer treatment accessible and affordable, raised a $5M seed funding.
The round was led by Andreessen Horowitz’s Bio fund, with participation from Lerer Hippeau and Y Combinator.
Led by founder and CEO Christina Lopes, One Health brings next-generation sequencing to veterinary cancer. FidoCure, its flagship product, allows users to purchase treatment plans for a fixed price and have access to canine cancer care.
One Health uses gene sequencing to understand the exact genetic mutation that is causing your dog’s cancer. Users receive recommendations to help understand what is driving their dog’s cancer and the best therapeutic implications. Genetic sequencing results are used to provide individualized, targeted treatment leveraging the latest science available in oncology.